Vertex, NHS have second meeting for CF medicines

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) said it had a second meeting with NHS England on May 25 to discuss access to Vertex's cystic fibrosis medicines. The company said there "is still some way to go to reach an agreement on how our innovative medicines should be valued." The parties will meet again "in the coming weeks."...